Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 56
Filtrer
1.
Med. crít. (Col. Mex. Med. Crít.) ; 36(4): 249-253, Jul.-Aug. 2022. graf
Article de Espagnol | LILACS-Express | LILACS | ID: biblio-1430756

RÉSUMÉ

Resumen: Introducción: Coccidioidomicosis y COVID-19 están catalogadas como patologías pulmonares primarias. Ambas presentan un cuadro inicial inespecífico; sin embargo, en fases avanzadas pueden requerir hospitalización, apoyo ventilatorio e ingreso a la unidad de terapia intensiva, manifestándose con un síndrome de insuficiencia respiratoria aguda severo. Caso clínico: Se describe el caso de una paciente, quien es ingresada a la unidad de terapia intensiva por presentar SIRA severo debido a COVID-19; sin embargo, muestra una evolución tórpida, por lo que se continúa su abordaje diagnóstico; se detectó coccidioidomicosis como enfermedad coexistente. Éste es el primer caso de coinfección COVID-19 coccidioidomicosis reportado en México en una revista de medicina crítica. Conclusión: El diagnóstico de coccidioidomicosis es aún más complejo debido a que puede pasar desapercibido, perdiéndose la oportunidad diagnóstica temprana, lo que está relacionado con una mala evolución posterior como sucedió en nuestro caso.


Abstract: Introduction: Coccidioidomycosis and COVID-19 are classified as primary pulmonary pathologies. Both present a nonspecific initial picture, however, in advanced phases they may require hospitalization, ventilatory support and admission to the intensive care unit, manifesting with a severe acute respiratory failure syndrome. Clinical case: The case of a female patient who is admitted to the intensive care unit for presenting severe SIRA due to COVID-19 is described, however, she presents a torpid evolution so her diagnostic approach is continued, finding coccidioidomycosis as a finding as coexisting disease. This being the first case reported in Mexico in a critical medicine journal. Conclusion: The diagnosis of coccidioidomycosis is even more complex because it can go unnoticed, losing the opportunity for an early diagnosis and this is related to a poor subsequent evolution as it happened in our case.


Resumo: Introdução: A coccidioidomicose e a COVID-19 são classificadas como patologias pulmonares primárias. Ambos apresentam um quadro inicial inespecífico, porém, em estágios avançados podem necessitar de internação, suporte ventilatório e internação em unidade de terapia intensiva, manifestando-se com síndrome de insuficiência respiratória aguda grave. Caso clínico: Descreve-se o caso de uma paciente do sexo feminino que está internada na unidade de terapia intensiva por apresentar SDRA grave por COVID-19, porém, apresenta evolução tórpida, então sua abordagem diagnóstica é continuada, encontrando como achado Coccidioidomicose como doença coexistente. Este é o primeiro caso relatado no México em uma revista medicina crítica. Conclusão: O diagnóstico da Coccidioidomicose é ainda mais complexo, pois pode passar despercebido, perdendo a oportunidade de diagnóstico precoce e isso está relacionado a uma evolução posterior ruim como aconteceu em nosso caso.

2.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;53: e20200249, 2020. tab, graf
Article de Anglais | SES-SP, ColecionaSUS, LILACS | ID: biblio-1136896

RÉSUMÉ

Abstract INTRODUCTION: Coccidioidomycosis, a disease caused by Coccidioides immitis or Coccidioides posadasii, is endemic in arid climatic regions in Northeast Brazil. Its prevalence is higher among young adult males living in rural areas. Existing literature about this disease in Ceará, a Northeast Brazilian state, are scarce. Here, we aimed to outline the clinical and epidemiological profiles, radiological patterns, and therapeutic responses of patients with coccidioidomycosis in a reference center in Ceará, Brazil. METHODS This is a descriptive study with quantitative analysis. Patients who underwent medical follow-up in São José Hospital of Infectious Diseases and received confirmed mycological diagnosis of coccidioidomycosis between January, 2007 and December 2017 were included. Epidemiological, clinical, radiological, and therapeutic response data were collected from medical charts. RESULTS Thirty patients were included. The patients were males with median age of 30 years, and 73% were considered to have high-risk exposure to Coccidioides owing to professional activities. Cough (96.7%), dyspnea (63.3%), fever (86.7%), and pleuritic pain (60%) were the most prevalent clinical manifestations. Interstitial pattern (91.3%) was the most frequent pulmonary radiological finding. Fluconazole, amphotericin B, and itraconazole were administered for treatment (in 82.1%, 42.8%, and 21.4% of cases, respectively). A favorable outcome was observed in 83.8% of patients. CONCLUSIONS Coccidioidomycosis was more prevalent in the central and southern regions of the State of Ceará. Understanding the local epidemiology and clinical manifestations of the disease, in addition to the pulmonary radiologic findings, may aid the early detection of coccidioidomycosis and facilitate early diagnosis.


Sujet(s)
Humains , Adulte , Coccidioïdomycose/traitement médicamenteux , Coccidioïdomycose/imagerie diagnostique , Brésil/épidémiologie , Fluconazole , Coccidioides , Itraconazole
3.
Zhongguo yi xue ke xue yuan xue bao ; Zhongguo yi xue ke xue yuan xue bao;(6): 646-657, 2019.
Article de Chinois | WPRIM | ID: wpr-775981

RÉSUMÉ

Objective To summarize the characteristics of Chinese coccidioidomycosis cases, improve the diagnosis and treatment of this disease and prevent misdiagnosis as well as therapeutic error.Methods Search in databases including Medline,Wanfang,and CNKI using "Coccidioidomycosis" and "China" as index words yielded 23 articles that reported a total of 32 Chinese coccidioidomycosis cases.In addition,one patient with disseminated coccidioidomycos was treated in our center in April 2016.The demographic data,site of infection,clinical manifestations,past medical history,exposure history,imaging and laboratory findings,and pathological features of these 33 patients were analyzed.Results Among these 33 patients,7(21.2%)had visited an epidemic area and 6(18.2%)were immunocompromised.The disease involved the respiratory system,skin,bone,central nervous system,cornea,and stomach in 24,6,3,2,1,and 1 patients,respectively.Eight patients (24.2%) had multiple system involvement,and three of them died.The imaging findings included pulmonary nodules(=14),mediastinal lymphadenopathy(=5),solid shadow(=4),cavity(=4),pleural effusion(=3),multiple plaques(=2)and masses(=2).Coccidiolys cysts were detected in the affected tissues(=28)or in pus,exudate or pleural smear(=3);in addition,coccidioides mycelium and spores were found in the sputum,pus,and tissue cultures in 4 cases,among whom only 2 cases were confirmed by serological examination.The treatments included triazoles(=20),systemic or local administration of amphotericin B(=13),surgical resection of the lesion(=8),and intravenous gamma globulin(=1).Five patients died,among whom three had underlying diseases that caused immunosuppression and one was an infant.The prognoses were relatively good in the remaining patients.Conclusions Early diagnosis and proper treatment can achieve good prognosis in coccidioidomycosis patients.Multi-system involvement and immunosuppression are risk factors for poor prognosis of coccidioidomycosis.For these patients,adequate and full-course medication may prevent rapid disease progression.


Sujet(s)
Humains , Chine , Coccidioides , Coccidioïdomycose , Diagnostic , Anatomopathologie , Thérapeutique , Pronostic
4.
Poblac. salud mesoam ; 15(2): 150-175, ene.-jun. 2018. tab, graf
Article de Espagnol | LILACS | ID: biblio-984806

RÉSUMÉ

Resumen Objetivo: Analizar la dinámica temporal de la coccidioido micosis en México, durante el periodo comprendido entre 2004-2015, en el contexto de sus determinantes socio ambientales e identificar su distribución actual en el territorio nacional mediante la construcción de indicadores de concentración geográfica. Métodos: Se conduce análisis exploratorio de datos a partir de microdatos sobre egresos hospitalarios en el periodo 2004-2015. En términos teóricos, la presente investigación se ubica en el paradigma sobre determinantes sociales y ambientales de las condiciones de salud pública. Resultados: La evolución temporal durante 11 años de información analizada permite identificar un patrón persistente en la concentración de casos, que afecta principalmente a cuatro estados en el país, con una clara carga para la población masculina. Se identifica al estado de Sonora como la entidad de mayor incidencia en México, una entidad cuyos determinantes ambientales analizados sugieren la necesidad de implementar políticas públicas preventivas. Conclusiones: Dada la evolución temporal de egresos hospitalarios por coccidiodomicosis en México y el vínculo ambiental de la enfermedad, la evidencia obtenida representa un área de oportunidad para intervenir mediante estrategias de control focalizadas en territorios específicos, siendo el estado de Sonora un sitio prioritario de atención.


Abstract Objective: To analyze the temporal dynamics of coccidioide mycosis in Mexico, during the period between 2004-2015 in the context of its socio-environmental determinants and to identify its actual distribution in the national territory by means of the construction of geographical concentration indicators. Methods: An exploratory analysis of data was made from micro data on hospital discharges in the period 2004-2015. In theoretical terms, this research is located in the paradigm on social and environmental determinants of public health conditions. Results: The time evolution during 11 years of analyzed information allows to identify a persistent pattern in the concentration of cases, which mainly affects four states in the country, with a clear burden for the male population. The state of Sonora was identified as the entity with the highest incidence in Mexico, an entity that determines the environmental factors analyzed and the need to implement preventive public policies. Conclusions: Given the temporal evolution of hospital discharges due to coccidioid mycosis in Mexico and the environmental link of the disease, the evidence obtained represents an opportunity to intervene through control strategies focused on specific territories, with the State of Sonora being a priority site of attention.


Sujet(s)
Humains , Morbidité , Coccidioides , Coccidioïdomycose/épidémiologie , Mexique
5.
Neumol. pediátr. (En línea) ; 13(1): 32-34, ene. 2018. ilus
Article de Espagnol | LILACS | ID: biblio-999238

RÉSUMÉ

Coccidioides is a fungus that is frequently found in dry places of sparse storms, with warm temperatures during most of the year. Two species are known to infect the human being: C. immitis and C. posadasii.It is endemic in northern Mexico, southern United States, as well as in some regions of Central America and South America. It is a highly contagious organism, but mostly it generates self-limited and asymptomatic diseases. Only 10 percent of cases with pulmonary symptoms are severe and may manifest as lobar pneumonia. Some cases of multiple foci and pleural effusion are diagnosed through biopsy with molecular methods. The treatment in many cases includes the use of azole antifungals for 3-6 months and follow-up with antibody titres


El Coccidioides es un hongo que se encuentra de manera frecuente en lugares secos, con temperaturas cálidas durante la mayoría del año. Son dos especies las que se conoce que infectan al ser humano la C. Immitis y C. Posadasii. Es endémico del norte de México, sur de Estados Unidos, así como algunas pequeñas regiones de centro y Sudamérica. Es un organismo altamente contagioso, pero en su mayoría genera enfermedades autolimitadas y de tipo asintomático, los pacientes con manifestaciones pulmonares solamenteen 10 por ciento son de presentación grave. Esta puede ser como una neumonía lobar, pero en algunos casos de focos múltiples y con derrame pleural, el diagnóstico es mediante biopsia en a fechas recientes con métodos moleculares. Los tratamientos en muchos casos requieren únicamente vigilancia. De requerir tratamiento se usa antimicótico 3-6 meses con azoles y seguimientos con títulos de anticuerpos


Sujet(s)
Humains , Mâle , Enfant , Épanchement pleural/diagnostic , Épanchement pleural/microbiologie , Coccidioïdomycose/complications , Coccidioïdomycose/diagnostic , Épanchement pleural/anatomopathologie , Épanchement pleural/imagerie diagnostique , Radiographie thoracique , Coccidioïdomycose/anatomopathologie , Coccidioïdomycose/imagerie diagnostique , Maladies endémiques
6.
Article de Anglais | WPRIM | ID: wpr-717733

RÉSUMÉ

OBJECTIVES: Imported systemic mycoses is a severe fungal infection that can cause diseases in healthy people. However, there is a serious lack of epidemiological data about imported systemic mycoses. Therefore, an epidemiological characterization of imported systemic mycoses in Korea was performed. METHODS: We collected health insurance data between 2008 and 2012 from the Health Insurance Corporation and analyzed the data to determine the prevalence and treatment management of imported systemic mycoses. RESULTS: The prevalence of imported systemic mycoses between 2008 and 2012 increased slowly by 0.49/100,000 to 0.53/100,000 persons. The prevalence of coccidioidomycosis increased from 0.28/100,000 in 2008 to 0.36/100,000 persons in 2012. A mean of 229.6 cases occurred each year. Children and the elderly showed higher prevalence than adults in the 20- to 59-year-old age group. The rate of infection according to region ranged from 0.18/100,000 persons in Ulsan, to 0.59/100,000 persons in Gyeonggi. The prevalence in females was higher than that in males. Inpatient treatment was 3.3% (38 cases), with 96.7% treated as outpatients. Hospitalizations cost 272.7 million won and outpatient treatments cost 111.7 million won. The treatment cost for coccidioidomycosis from 2008 to 2012 was 330.9 million won, with personal charges of 79.2 million won and insurance charges of 251.7 million won. Most of the expenses for the coccidioidomycosis treatment were for inpatient treatment. CONCLUSION: The results in this study may be a useful resource for determining the changes in the trend of imported systemic mycoses.


Sujet(s)
Adulte , Sujet âgé , Enfant , Femelle , Humains , Mâle , Adulte d'âge moyen , Blastomycose , Coccidioïdomycose , Épidémiologie , Coûts des soins de santé , Histoplasmose , Hospitalisation , Patients hospitalisés , Assurance , Assurance maladie , Corée , Mycoses , Patients en consultation externe , Prévalence
7.
Invest. clín ; Invest. clín;56(4): 411-420, dic. 2015. ilus
Article de Espagnol | LILACS | ID: biblio-829035

RÉSUMÉ

La coccidioidomicosis es una micosis sistémica endémica del continente americano, causada por un hongo dimórfico. La inhalación de artroconidios transportados por el viento permite la colonización del tejido pulmonar produciendo la micosis. El diagnóstico se realiza a través del estudio epidemiológico y micológico, complementándose con el histopatológico, inmunitario y molecular. En Venezuela ha sido reportada desde 1948 cuando el Dr. Humberto Campins describió el primer caso en Barquisimeto, estado Lara. Las micosis en Venezuela no son enfermedades de denuncia obligatoria por lo que existe un grave subregistro en las estadísticas anuales del país, sin embargo, los Grupos de Trabajo en Micología logran mantener la data de los casos. Los datos aportados acerca de las variables bioclimáticas y ambientales de las zonas endémicas pueden contribuir a la búsqueda del nicho ecológico del hongo, para así apoyar la vigilancia eco-epidemiológica de los casos clínicos y la pesquisa de casos subclínicos, fortaleciendo el sistema preventivo de salud y el manejo médico oportuno de la micosis.


Coccidioidomycosis is a systemic fungal infection endemic in the Americas, caused by a dimorphic fungus. Inhalation of arthroconidia transported by wind colonize lung tissue causing mycosis. Diagnosis is made through epidemiological and mycological study, complemented by histopathological, molecular and immune response. In Venezuela it has been reported since 1948 when Dr. Humberto Campins described the first case in Barquisimeto, Lara state. The fungal diseases in Venezuela are not mandatory notification, so that t6here is a serious underreporting in the annual statistics of the country; however, the working groups in Mycology manage to keep the data of the cases. The information provided by bioclimatic and environmental variables in endemic areas can contribute to the pursuit of ecological niches of the fungus in order to strengthen eco-epidemiological surveillance of clinical cases and research subclinical cases, strengthening the preventive health system and appropriate medical management of mycosis.


Sujet(s)
Humains , Coccidioïdomycose/épidémiologie , Maladies endémiques , Venezuela/épidémiologie , Coccidioïdomycose/diagnostic
8.
An. bras. dermatol ; An. bras. dermatol;90(5): 610-619, graf
Article de Anglais | LILACS | ID: lil-764414

RÉSUMÉ

AbstractCoccidioidomycosis is a highly prevalent disease in the Western hemisphere. It is considered one of the most virulent primary fungal infections. Coccidioides species live in arid and semi-arid regions, causing mainly pulmonary infection through inhalation of arthroconidia although many other organs can be affected. Primary inoculation is rare. Since the first case of coccidioidomycosis was reported in 1892, the skin has been identified as an important target of this disease. Knowledge of cutaneous clinical forms of this infection is important and very useful for establishing prompt diagnosis and treatment. The purpose of this article is to provide a review of this infection, emphasizing its cutaneous manifestations, diagnostic methods and current treatment.


Sujet(s)
Femelle , Humains , Mâle , Coccidioïdomycose/anatomopathologie , Mycoses cutanées/anatomopathologie , Coccidioïdomycose/classification , Coccidioïdomycose/thérapie , Mycoses cutanées/thérapie , Mycoses pulmonaires/anatomopathologie , Mycoses pulmonaires/thérapie , Facteurs de risque , Peau/anatomopathologie
9.
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;57(supl.19): 51-56, Sept. 2015.
Article de Anglais | LILACS | ID: lil-762054

RÉSUMÉ

SUMMARYTherapy of coccidioidomycosis continues to evolve. For primary pulmonary disease, antifungal therapy is frequently not required while prolonged courses of antifungals are generally needed for those in whom extrathoracic disseminated has occurred. Intravenous amphotericin B should be reserved for those with severe disease. Oral triazole antifungals have had a great impact on the management of coccidioidomycosis. Both fluconazole and itraconazole at 400 mg daily have been effective for various forms of coccidioidomycosis, including meningitis, although relapse after therapy is discontinued is a problem. Individuals with suppressed cellular immunity are at increased risk for symptomatic coccidioidomycosis and they include those with HIV infection, those on immunosuppressive medications, and those who have received a solid organ transplant. Pregnant women and African-American men have been identified as two other groups who are at an increased risk for symptomatic and severe infection.


RESUMOA terapia da coccidioidomicose continua a evoluir. Para a doença pulmonar primária, o tratamento antifúngico frequentemente não é necessário, enquanto períodos prolongados de tratamento antifúngico são geralmente necessários para aqueles nos quais houve disseminação extratorácica. A anfotericina B intravenosa deve ser reservada para pacientes com doença grave. Antifúngicos triazólicos orais têm tido um grande impacto no manejo da coccidioidomicose. Tanto fluconazol quanto itraconazol em doses diárias de 400 mg foram eficazes contra várias formas de coccidioidomicose, incluindo a meníngea, embora recaídas após a interrupção da terapia ainda constituam um problema. Indivíduos com supressão da imunidade celular apresentam risco aumentado para a coccidioidomicose sintomática, incluindo pacientes infectados pelo HIV, em uso de medicações imunossupressoras, e os que receberam transplantes de órgãos sólidos. Mulheres grávidas e homens afro-americanos foram identificados como dois outros grupos que apresentam risco aumentado de infecção sintomática e grave.


Sujet(s)
Humains , Femelle , Grossesse , Antifongiques/usage thérapeutique , Coccidioïdomycose/traitement médicamenteux , Infections à VIH/complications , Infections à VIH/microbiologie , Mycoses pulmonaires/traitement médicamenteux , Indice de gravité de la maladie
10.
Rev. chil. infectol ; Rev. chil. infectol;32(3): 339-343, jun. 2015. ilus, tab
Article de Espagnol | LILACS | ID: lil-753493

RÉSUMÉ

Coccidioidomycosis is a systemic airborne mycosis that may involve secondarily other organs through systemic dissemination. Fungi Coccidioides immitis and C. posadasii are the etiologic agents. The former is ubiquitous from the area of California in North America, and the latter is found elsewhere in the world. Primary cutaneous infection is rare. We present six Mexican male cases, residents of Tijuana B.C. Three of them with primary pulmonary infection and further cutaneous dissemination, and three cases of primary cutaneous coccicioidomycosis. In half the cases C. posadasii was isolated. The clinical suspicion is basic for reaching the diagnosis, and we must always keep in mind that the cutaneous manifestations are widely varied and that the lesions are more severe when systemic dissemination occurs.


La coccidioidomicosis es una micosis con vía de entrada inhalatoria que puede tener manifestaciones secundarias en otros órganos, y diseminación sistèmica. Se han identificado como agentes etiológicos a Coccidioides immitis y C. posadasii, El primero está presente en California de Norteamérica y el segundo en cualquier otra región del mundo. La infección cutánea primaria es una presentación poco común. Presentamos seis casos clínicos mexicanos, de sexo masculino, residentes de la ciudad de Tijuana, B.C. Tres de ellos con infección pulmonar primaria y diseminación cutánea y tres cutáneos primarios. En la mitad de los casos se logró aislar C. posadasii. La sospecha clínica es fundamental para llegar al diagnóstico ya que las manifestaciones cutáneas son muy variadas, y ante diseminación sistèmica las lesiones cutáneas son más graves.


Sujet(s)
Adulte , Humains , Mâle , Adulte d'âge moyen , Coccidioïdomycose/diagnostic , Mycoses cutanées/diagnostic
11.
Article de Anglais | WPRIM | ID: wpr-44741

RÉSUMÉ

Coccidioidomycosis is a fungal infection caused by Coccidioides immitis. The endemic area is mostly south-western United States. As increasing in overseas travel to endemic areas, the incidence rate has been recently increased in non-endemic areas. The diagnosis may be delayed in non-endemic area. It is important to elicit traveling histories and to differentiate lung consolidation with eosinophilia, for timely diagnosis of coccidioidomycosis. Recently, we experienced a case with pulmonary coccidioidomycosis in a Korean American who visited Korea showed consolidation in right lower lobe on chest X-ray and prolonged eosinophilia. In the case, a confirmatory diagnostic method was percutaneous transthoracic needle biopsy of lung. We report acute pulomonary coccidioidomycosis case and review previous published reports with pulmonary manifestation in Korea.


Sujet(s)
Humains , 23895 , Ponction-biopsie à l'aiguille , Coccidioides , Coccidioïdomycose , Diagnostic , Maladies endémiques , Éosinophilie , Incidence , Corée , Mycoses pulmonaires , Poumon , Thorax , États-Unis
12.
Rev. am. med. respir ; 14(1): 61-74, mar. 2014. ilus, tab
Article de Espagnol | LILACS | ID: lil-708622

RÉSUMÉ

La coccidiodomicosis es una micosis sistémica endémica de América, producida por los hongos del género Coccidioides, C. immitis y C. posadasii. La mayor parte de las infecciones son benignas y autolimitadas, muy pocas desarrollan una enfermedad pulmonar grave y, un porcentaje mínimo, una enfermedad diseminada. Las infecciones complicadas del espacio pleural se han comunicado en muy pocos casos en la literatura. Se presenta el caso de un paciente inmunocompetente con una forma cavitada extensa asociada a empiema.


Coccidioidomycosis is a systemic mycosis endemic in America, caused by Coccidioides immitis and Coccidioides posadasii. Most of the infections are mild and self-limited; only a few of them develop a serious lung disease and a much smaller proportion cause a systemic disease. A few cases of infections complicating the pleural space infections have been reported in the literature. We present a case of an immunocompetent patient, with a pulmonary Coccidiodiomycosis with extensive cavitary dissease associated to empyema.


Sujet(s)
Coccidioïdomycose , Empyème , Mycoses
13.
Rev. chil. infectol ; Rev. chil. infectol;30(6): 669-672, dic. 2013. ilus
Article de Espagnol | LILACS | ID: lil-701717

RÉSUMÉ

Treatment failure in community-acquired pneumonia is defined as a clinical condition with inadequate response to antimicrobial therapy. Resistant and unusual microorganisms and noninfectious causes are responsible for treatment failure. Coccidioides immitis is a fungus that causes pneumonia in the northern hemisphere, especially in the United States and northern Mexico. We report a case of pulmonary coccidioidomycosis imported from Mexico to Chile. After a comprehensive study, histopathology was able to establish Coccidiodes immitis as the causative agent, achieving clinical and radiological improvement with antifungal therapy.


La neumonía de evolución tórpida son aquellas en que no se logra una respuesta clínica adecuada con el uso de terapia antimicrobiana. Existen múltiples causas a esta falta de respuesta: resistencia antimicrobiana, microorganismos no cubiertos o infecciones por microorganismos atípicos. Coccidioides immitis es un hongo causante de neumonía en el hemisferio norte, especialmente en E.U.A y norte de México. No existen reportes de casos pulmonares importados en Chile. Presentamos el caso de una mujer adulta con una neumonía que no respondió al tratamiento antimicrobiano habitual. Una vez realizado un estudio exhaustivo, se logró establecer mediante el estudio histopatológico la existencia de una coccidiodomicosis como entidad causal, logrando una respuesta clínica y radiológica favorable al tratamiento antifúngico.


Sujet(s)
Femelle , Humains , Adulte d'âge moyen , Coccidioïdomycose , Mycoses pulmonaires , Antifongiques/usage thérapeutique , Chili , Coccidioïdomycose/diagnostic , Coccidioïdomycose/traitement médicamenteux , Infections communautaires/diagnostic , Infections communautaires/traitement médicamenteux , Infections communautaires/microbiologie , Diagnostic différentiel , Mycoses pulmonaires/diagnostic , Mycoses pulmonaires/traitement médicamenteux , Mycoses pulmonaires/microbiologie , Mexique , Pneumopathie infectieuse/diagnostic , Voyage , Échec thérapeutique
14.
An. bras. dermatol ; An. bras. dermatol;88(2): 287-289, abr. 2013. graf
Article de Anglais | LILACS | ID: lil-674171

RÉSUMÉ

A 55-year-old male presented with back pain and slightly tender annular plaques with central ulceration on his face. A skin biopsy revealed scattered yeast with broad based buds. A CT scan of the abdomen revealed a pathologic T12 fracture. Tissue obtained from the spine confirmed budding yeasts. The patient was diagnosed with disseminated blastomycosis. The patient was treated with amphotericin and itraconazole and completely recovered. .


Paciente do sexo masculino, com 55 anos de idade, compareceu ao ambulatório com dores na costa e placas anulares ligeiramente sensíveis, com ulceração central na face. Uma biópsia cutânea revelou levedura disseminada, com brotos de base larga. A tomografia computadorizada do abdômen revelou uma fratura patológica da T12. Amostra de tecido obtido da coluna vertebral confirmou levedura em fase de brotamento. O paciente foi diagnosticado com blastomicose disseminada. Após tratamento com anfotericina e itraconazol, o paciente teve recuperação completa. .


Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Blastomycose/anatomopathologie , Dermatoses faciales/anatomopathologie , Amphotéricine B/usage thérapeutique , Antifongiques/usage thérapeutique , Biopsie , Blastomycose/traitement médicamenteux , Dermatoses faciales/traitement médicamenteux , Peau/anatomopathologie , Fractures du rachis/diagnostic , Résultat thérapeutique
15.
Article de Chinois | WPRIM | ID: wpr-436811

RÉSUMÉ

Objective To evaluate the findings of computerized tomography (CT) imaging in patients with primary pulmonary fungal infections.Methods CT findings and clinical data of 18 cases of primary pulmonary fungal infections from 2004 to 2012 were retrospectively analyzed.The diagnoses of all patients were confirmed by pathology or serology.Results The CT of primary pulmonary fungal infections showed soft tissue density nodules in 15 out of 18 cases,and masses in 3 out of 18.By pathology or serological examination,there were 12 cases of Aspergillus infections,3 cases of cryptococcal infections and 3 cases of coccidioidomycosis.The CT findings of all of the 12 cases of Aspergillus infection showed quasi-circular shaped lesions,with lobulation and spiculation (6/12),bronchial through syndrome (3/12),the air crescent sign (6/12),or mediastinal/hilar lymphadenopathies (3/12).Six cases presenting air crescent sign were all diagnosed with primary pulmonary aspergillosis.Among 12 aspergillosis cases,6 cases underwent CT enhancement scan,among which 3 showed no enhancement and 3 showed slight enhancements.The CT findings of all eases of Cryptococcus neoformans infections were cauliflower-like shape,with lobulation,spiculation,and no focal point calcification or mediastinal/hilar lymphadenopathies.After enhancement,all of the lesions were enhanced heterogeneously.The CT findings of all the coccidioidomycosis were irregular shaped lesions with halo sign and mediastinal/hilar lymphadenopathies.All 3 cases of halo signs were diagnosed with primary coccidioidal infections.Conclusions The CT findings of primary pulmonary fungal infections have certain characteristics.Diagnosis could be made based on CT imaging together with clinical manifestations before pathological results are available.

16.
Article de Anglais | WPRIM | ID: wpr-53536

RÉSUMÉ

Vaccines against fungal diseases are gaining attention because of their growing impact on modern medicine. Development of these vaccines should incorporate immunological tools that integrate with or replace chemotherapy to minimize antibiotic use and consequent resistance. In this review, we evaluate the current developmental status of fungal vaccines against coccidioidomycosis. There is a need for a vaccine that sufficiently prevents disease, without eradicating the fungus, by neutralizing adhesions and enzymes or other low penetrance virulence traits.


Sujet(s)
Animaux , Humains , Coccidioides/immunologie , Coccidioïdomycose/immunologie , Vaccins antifongiques/usage thérapeutique , Virulence
17.
Mem. Inst. Oswaldo Cruz ; 107(6): 813-815, set. 2012. ilus
Article de Anglais | LILACS | ID: lil-649499

RÉSUMÉ

Coccidioidomycosis is a systemic mycosis with a variable clinical presentation. Misdiagnosis of coccidioidomycosis as bacterial pneumopathy leads to inappropriate prescription of antibiotics and delayed diagnosis. This report describes an outbreak among armadillo hunters in northeastern Brazil in which an initial diagnosis of bacterial pneumonia was later confirmed as coccidioidomycosis caused by Coccidioides posadasii. Thus, this mycosis should be considered as an alternative diagnosis in patients reporting symptoms of pneumonia, even if these symptoms are only presented for a short period, who are from areas considered endemic for this disease.


Sujet(s)
Adolescent , Animaux , Humains , Mâle , Adulte d'âge moyen , Tatous/microbiologie , Coccidioïdomycose/diagnostic , Mycoses pulmonaires/diagnostic , Pneumopathie bactérienne/diagnostic , Pneumopathie infectieuse/diagnostic , Brésil/épidémiologie , Coccidioides/isolement et purification , Coccidioïdomycose/épidémiologie , Épidémies de maladies , Mycoses pulmonaires/épidémiologie , Pneumopathie bactérienne/traitement médicamenteux , Pneumopathie infectieuse/épidémiologie , Microbiologie du sol
18.
Korean Journal of Medicine ; : 734-738, 2012.
Article de Coréen | WPRIM | ID: wpr-187682

RÉSUMÉ

Coccidioidomycosis, a fungal infection caused by the fungus known as Coccidioides immitis, can affect many species of mammals and some reptiles. The fungus is endemic in the soil of the southwestern United States, Mexico, and parts of Central and South America. Most infections in humans are relatively mild or asymptomatic, but severe or fatal illness can also occur, especially in the elderly or immunocompromised. We report on a patient with disseminated coccidioidomycosis whose lymph nodes, skin, and especially brain were infected at diagnosis; however, the lung parenchyme was not infected. Because the brain infection could have been a fatal complication in this peculiar case, we recommended life-long fluconazole treatment for the patient. After 2 months of high doses of fluconazole, the patient's clinical signs were greatly improved with respect to fever, headache, skin lesions, and mediastinal widening on the chest X-ray.


Sujet(s)
Sujet âgé , Humains , Encéphale , Coccidioides , Coccidioïdomycose , Fièvre , Fluconazole , Champignons , Céphalée , Poumon , Noeuds lymphatiques , Mammifères , Mexique , Reptiles , Peau , Sol , Amérique du Sud , États du Sud-Ouest des États-Unis , Thorax
19.
Korean Journal of Medicine ; : 734-738, 2012.
Article de Coréen | WPRIM | ID: wpr-741106

RÉSUMÉ

Coccidioidomycosis, a fungal infection caused by the fungus known as Coccidioides immitis, can affect many species of mammals and some reptiles. The fungus is endemic in the soil of the southwestern United States, Mexico, and parts of Central and South America. Most infections in humans are relatively mild or asymptomatic, but severe or fatal illness can also occur, especially in the elderly or immunocompromised. We report on a patient with disseminated coccidioidomycosis whose lymph nodes, skin, and especially brain were infected at diagnosis; however, the lung parenchyme was not infected. Because the brain infection could have been a fatal complication in this peculiar case, we recommended life-long fluconazole treatment for the patient. After 2 months of high doses of fluconazole, the patient's clinical signs were greatly improved with respect to fever, headache, skin lesions, and mediastinal widening on the chest X-ray.


Sujet(s)
Sujet âgé , Humains , Encéphale , Coccidioides , Coccidioïdomycose , Fièvre , Fluconazole , Champignons , Céphalée , Poumon , Noeuds lymphatiques , Mammifères , Mexique , Reptiles , Peau , Sol , Amérique du Sud , États du Sud-Ouest des États-Unis , Thorax
20.
Article de Coréen | WPRIM | ID: wpr-154689

RÉSUMÉ

A 35-year-old man with known coccidioidal meningitis developed a severe headache and vomiting during routine treatment. Hydrocephalus was visible on brain imaging, and CSF study revealed pleocytosis, lowering of glucose, and increased intracranial pressure. Dexamethasone and mannitol was used for intracranial pressure control. Intrathecal amphotericin B administration and switching to itraconazole resulted in gradual improvement of symptoms. After 4 months of discontinuing amphotericin B intrathecal administration, the patient developed severe headaches with vomiting, diplopia and tandem gait. Coccidioidal meningitis aggravation was suspected based on brain MRI and CSF studies. Ventriculo-peritoneal shunt insertion was performed for intracranial pressure control and the combined therapy of intrathecal amphotericin B administration and fluconazole was maintained. This combined regimen kept the meningitis stable for 1 month.


Sujet(s)
Adulte , Humains , Amphotéricine B , Encéphale , Coccidioïdomycose , Dexaméthasone , Diplopie , Fluconazole , Démarche , Glucose , Céphalée , Hydrocéphalie , Pression intracrânienne , Itraconazole , Hyperleucocytose , Mannitol , Méningite , Neuroimagerie , Dérivation ventriculopéritonéale , Vomissement
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE